Article

LRH-1 as a target for the development of new breast cancer therapies

2015-01-01

Abstract excerpt

Estrogen drives the growth and development of estrogen receptor alpha (ERα) positive breast cancer and ERα is the target for hormonal therapies that inhibit its activity. A substantial proportion of patients become resistant to these therapies, demonstrating a need for new therapies. Gene expression microarray studies have been performed with a view to identifying potential novel therapeutic targets, biomarkers or...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3e0d734e-60b2-5afe-957f-238dc2b68f2e
DOI: 10.25560/55285

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

LRH-1 as a target for the development of new breast cancer therapiesDOI 10.25560/55285Read

LRH-1 as a key regulator of estrogen responses in breast cancer cellsSemantic proximity Read

ALDH1A1 in breast cancer: A prospective target to overcome therapy resistance (Review)Semantic proximity Read

LRH1 promotes tumor cell proliferation and migration, and is correlated with poor prognosis in ovarian cancerSemantic proximity Read

LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21Semantic proximity Read

LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancerSemantic proximity Read

Liver Receptor Homolog-1 (LRH-1/NR5A2) orchestrates hepatic inflammation and TNF-induced cell deathSemantic proximity Read

Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation.Semantic proximity Read

Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferationSemantic proximity Read

ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers.Semantic proximity Read

Silencing LRH-1 in colon cancer cell lines impairs proliferation and alters gene expression programsSemantic proximity Read

Development of a new class of liver receptor homolog-1 (LRH-1) agonists by photoredox conjugate additionSemantic proximity Read

Development of the first low nanomolar Liver Receptor Homolog-1 agonist through structure-guided designSemantic proximity Read